Concurrent prescribing of opioids with other sedating medications after cancer diagnosis: a population-level analysis

[1]  N. Moryl,et al.  Safety of opioid prescribing among older cancer survivors , 2021, Cancer.

[2]  P. Kabos,et al.  New Persistent Opioid and Benzodiazepine Use After Curative-Intent Treatment in Patients With Breast Cancer. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  Diane D. Liu,et al.  Frequency of Concomitant Use of Gabapentinoids and Opioids among Patients with Cancer-Related Pain at an Outpatient Palliative Care Clinic. , 2020, Journal of Palliative Medicine.

[4]  A. Roberts.  Naloxone Prescribing Among Frequent Opioid Prescribers in Medicare Part D from 2013 to 2017: a Retrospective Study , 2020, Journal of general internal medicine.

[5]  P. Borzi,et al.  Centers for Medicare and Medicaid Services , 2020, Definitions.

[6]  Cancer Care Outcomes Research and Surveillance Consortium , 2020, Definitions.

[7]  C. Friese,et al.  Use of gabapentinoid medications among US adults with cancer, 2005–2015 , 2019, Supportive Care in Cancer.

[8]  D. Check,et al.  Concurrent Opioid and Benzodiazepine Prescriptions among Older Women Diagnosed with Breast Cancer. , 2019, Journal of the National Cancer Institute.

[9]  D. Kelley,et al.  Opioid Prescribing Safety Measures in Medicaid Enrollees With and Without Cancer. , 2019, American journal of preventive medicine.

[10]  W. van den Brink,et al.  Public Perceptions of Firearm- and NonFirearm-Related Violent Death in the United States: A National Study , 2018, Annals of Internal Medicine.

[11]  Inmaculada Hernandez,et al.  Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries , 2018, JAMA network open.

[12]  W. van den Brink,et al.  Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control study , 2017, PLoS medicine.

[13]  L. Baker,et al.  Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis , 2017, British Medical Journal.

[14]  E. Bruera,et al.  Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Dara Ganoczy,et al.  Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study , 2015, BMJ : British Medical Journal.

[16]  I. Kawachi,et al.  Disparities in perceived unmet need for supportive services among patients with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium , 2014, Cancer.

[17]  Andrew F Olshan,et al.  Big Data for Population-Based Cancer Research , 2014, North Carolina Medical Journal.

[18]  Shelli R. Kesler,et al.  Prevalence, mechanisms, and management of cancer-related cognitive impairment , 2014, International review of psychiatry.

[19]  Kathleen Saunders,et al.  Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders , 2009, PAIN.

[20]  J. McNeill,et al.  Unequal quality of cancer pain management: disparity in perceived control and proposed solutions. , 2007, Oncology nursing forum.

[21]  C. Weisner,et al.  Nonmedical use of prescription drugs among a longitudinal sample of dependent and problem drinkers. , 2007, Drug and alcohol dependence.

[22]  Jürgen Unützer,et al.  Clinician Screening and Treatment of Alcohol, Drug, and Mental Problems in Primary Care: Results From Healthcare for Communities , 2004, Medical care.

[23]  R. Jamison,et al.  Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. , 2004, Journal of pain and symptom management.

[24]  G. Zou,et al.  A modified poisson regression approach to prospective studies with binary data. , 2004, American journal of epidemiology.

[25]  J. Sloan,et al.  Dyspnea in cancer patients: prevalence and associated factors. , 2001, Journal of pain and symptom management.

[26]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.

[27]  C. Cleeland,et al.  Pain and Treatment of Pain in Minority Patients with Cancer: The Eastern Cooperative Oncology Group Minority Outpatient Pain Study , 1997, Annals of Internal Medicine.

[28]  Hodgkin Lymphoma.  NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines , 2014 .